The global biopreservation market is witnessing remarkable growth, valued at USD 3.47 Billion in 2024 and projected to reach USD 33.14 Billion by 2033, growing at a CAGR of 28.5% (2025–2033). This surge is fueled by the rising prevalence of chronic diseases, the increasing importance of personalized medicine, and growing investments in life sciences and biotechnology.
Biopreservation is vital in maintaining the integrity, viability, and functionality of biological samples such as cells, tissues, and organs. It plays a crucial role in biobanking, regenerative medicine, drug discovery, and transplantation, ensuring that valuable biological materials remain stable for scientific and medical applications. By utilizing advanced techniques like cryopreservation, cryoprotectants, and hypothermic storage, the industry continues to expand its scope and potential.
Market Dynamics
Growth Factors
- Increasing demand for biobanking services to support precision medicine and research.
- Adoption of omics technologies like genomics and proteomics, driving demand for high-quality biospecimens.
- Rising investments in R&D by governments, academia, and private organizations.
Restraints
- High costs associated with advanced biopreservation equipment and operations.
- Regulatory compliance and accreditation standards adding to financial burdens.
Opportunities
- Expanding applications in cell and gene therapy, with breakthroughs in CAR-T therapies and FDA approvals.
- Technological advancements in cryoprotectants, automated systems, and efficient storage solutions.
Regional Insights
- North America dominates the market with a 40% share, fueled by strong R&D investments and biobanking demand.
- Asia-Pacific is expected to grow fastest with a 28.8% CAGR, supported by increasing chronic disease prevalence and biobank development.
- Europe continues to be attractive due to government-backed biobank initiatives such as the UK Biobank.
- Latin America shows potential growth, while the Middle East & Africa market remains limited due to underdeveloped infrastructure.
Key Players in the Biopreservation Market
- Azenta US, Inc.
- Biomatrica, Inc.
- BioLife Solutions
- MVE Biological Solutions
- LabVantage Solutions, Inc.
- Taylor-Wharton
- Thermo Fisher Scientific, Inc.
- Panasonic Corporation
- X-Therma Inc.
- PrincetonCryo
- Stirling Ultracold
Recent Developments
- Feb 2024: Azenta launched BioArc™ Ultra, an automated eco-friendly ultracold sample management solution.
- Feb 2024: LabVantage introduced a digitally native ecosystem to accelerate R&D.
- Apr 2024: Thermo Fisher unveiled ENERGY STAR Certified TSX Universal ULT Freezers for improved temperature control.
Market Segmentation
By Product
- Equipment
- Media
- Laboratory Information Management System (LIMS)
By Application
- Regenerative Medicine
- Bio-Banking
- Drug Discovery
By Region
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America
About Us
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.
Contact Us
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/